Related Experiment Video
Updated: Feb 9, 2026

Advanced Glycation End-Products Sensitize Human Sensory-Like Neuron Cells to Capsaicin-Induced Calcium Influx
Published on: May 2, 2025
Diphlorethohydroxycarmalol Attenuates Methylglyoxal-Induced Oxidative Stress and Advanced Glycation End Product
Seon-Heui Cha1,2,3, Yongha Hwang1,2, Soo-Jin Heo4
1College of Pharmacy, Gachon University, Incheon 21936, Republic of Korea.
Abstract:
Diabetic nephropathy is the leading cause of end-stage renal disease in patients with diabetes mellitus. Oxidative stress has been shown to play an important role in pathogeneses of renal damage in diabetic patients. Here, we investigated the protective effect of diphlorethohydroxycarmalol (DPHC), which is a polyphenol isolated from an edible seaweed, Ishige okamurae, on methylglyoxal-induced oxidative stress in HEK cells, a human embryonic kidney cell line. DPHC treatment inhibited methylglyoxal- (MGO-) induced cytotoxicity and ROS production. DPHC activated the Nrf2 transcription factor and increased the mRNA expression of antioxidant and detoxification enzymes, consequently reducing MGO-induced advanced glycation end product formation. In addition, DPHC increased glyoxalase-1 mRNA expression and attenuated MGO-induced advanced glycation end product formation in HEK cells. These results suggest that DPHC possesses a protective activity against MGO-induced cytotoxicity in human kidney cells by preventing oxidative stress and advanced glycation end product formation. Therefore, it could be used as a potential therapeutic agent for the prevention of diabetic nephropathy.
Insights
Diphlorethohydroxycarmalol (DPHC), a seaweed polyphenol, protects human kidney cells from damage caused by methylglyoxal. This compound reduces oxidative stress and advanced glycation, offering potential for preventing diabetic nephropathy.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Diabetic nephropathy is a major cause of end-stage renal disease.
- Oxidative stress is a key factor in diabetic kidney damage.
- Methylglyoxal (MGO) is implicated in the pathogenesis of diabetic complications.
Purpose of the Study:
- To investigate the protective effects of diphlorethohydroxycarmalol (DPHC) against MGO-induced oxidative stress in human embryonic kidney (HEK) cells.
- To explore the underlying mechanisms of DPHC's protective action.
Main Methods:
- HEK cells were treated with MGO and/or DPHC.
- Cytotoxicity and reactive oxygen species (ROS) production were measured.
- Nrf2 activation, antioxidant enzyme mRNA expression, and glyoxalase-1 mRNA expression were assessed.
- Advanced glycation end product (AGE) formation was quantified.
Main Results:
- DPHC significantly inhibited MGO-induced cytotoxicity and ROS production in HEK cells.
- DPHC treatment activated the Nrf2 transcription factor, increasing antioxidant and detoxification enzyme expression.
- DPHC attenuated MGO-induced AGE formation by increasing glyoxalase-1 mRNA expression.
Conclusions:
- DPHC exhibits protective effects against MGO-induced kidney cell damage by mitigating oxidative stress and AGE formation.
- DPHC demonstrates potential as a therapeutic agent for preventing diabetic nephropathy.
More Related Videos
Related Concept Videos
Transcription Attenuation in Prokaryotes
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
Oxidation Numbers
Kidney Structure
Oxidation-Reduction Reactions
Filtration and Urine Formation
Pyruvate Oxidation
First, the enzyme pyruvate dehydrogenase removes the carboxyl group from pyruvate and releases it as carbon dioxide. The stripped molecule is then oxidized and releases electrons, which are then picked up by NAD+...

